NRBO Intrinsic Valuation and Fundamental Analysis - Neurobo Pharmaceuticals Inc - Alpha Spread

Neurobo Pharmaceuticals Inc
NASDAQ:NRBO

Watchlist Manager
Neurobo Pharmaceuticals Inc Logo
Neurobo Pharmaceuticals Inc
NASDAQ:NRBO
Watchlist
Price: 2.65 USD -1.85% Market Closed
Market Cap: 21.8m USD
Have any thoughts about
Neurobo Pharmaceuticals Inc?
Write Note

Intrinsic Value

NRBO doesn't have a meaningful market cap.
NRBO's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one NRBO stock under the Base Case scenario is 3.4 USD. Compared to the current market price of 2.65 USD, Neurobo Pharmaceuticals Inc is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NRBO Intrinsic Value
3.4 USD
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Neurobo Pharmaceuticals Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NRBO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NRBO?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Neurobo Pharmaceuticals Inc

Provide an overview of the primary business activities
of Neurobo Pharmaceuticals Inc.

What unique competitive advantages
does Neurobo Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Neurobo Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Neurobo Pharmaceuticals Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neurobo Pharmaceuticals Inc.

Provide P/S
for Neurobo Pharmaceuticals Inc.

Provide P/E
for Neurobo Pharmaceuticals Inc.

Provide P/OCF
for Neurobo Pharmaceuticals Inc.

Provide P/FCFE
for Neurobo Pharmaceuticals Inc.

Provide P/B
for Neurobo Pharmaceuticals Inc.

Provide EV/S
for Neurobo Pharmaceuticals Inc.

Provide EV/GP
for Neurobo Pharmaceuticals Inc.

Provide EV/EBITDA
for Neurobo Pharmaceuticals Inc.

Provide EV/EBIT
for Neurobo Pharmaceuticals Inc.

Provide EV/OCF
for Neurobo Pharmaceuticals Inc.

Provide EV/FCFF
for Neurobo Pharmaceuticals Inc.

Provide EV/IC
for Neurobo Pharmaceuticals Inc.

Show me price targets
for Neurobo Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Neurobo Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Neurobo Pharmaceuticals Inc?

What are the Net Income projections
for Neurobo Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Neurobo Pharmaceuticals Inc?

What are the EPS projections
for Neurobo Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Neurobo Pharmaceuticals Inc?

What are the EBIT projections
for Neurobo Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Neurobo Pharmaceuticals Inc?

Compare the revenue forecasts
for Neurobo Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neurobo Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neurobo Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neurobo Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Neurobo Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Neurobo Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Neurobo Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Neurobo Pharmaceuticals Inc.

Provide ROE
for Neurobo Pharmaceuticals Inc.

Provide ROA
for Neurobo Pharmaceuticals Inc.

Provide ROIC
for Neurobo Pharmaceuticals Inc.

Provide ROCE
for Neurobo Pharmaceuticals Inc.

Provide Gross Margin
for Neurobo Pharmaceuticals Inc.

Provide Operating Margin
for Neurobo Pharmaceuticals Inc.

Provide Net Margin
for Neurobo Pharmaceuticals Inc.

Provide FCF Margin
for Neurobo Pharmaceuticals Inc.

Show all solvency ratios
for Neurobo Pharmaceuticals Inc.

Provide D/E Ratio
for Neurobo Pharmaceuticals Inc.

Provide D/A Ratio
for Neurobo Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Neurobo Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Neurobo Pharmaceuticals Inc.

Provide Quick Ratio
for Neurobo Pharmaceuticals Inc.

Provide Current Ratio
for Neurobo Pharmaceuticals Inc.

Provide Cash Ratio
for Neurobo Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Neurobo Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Neurobo Pharmaceuticals Inc?

What is the current Free Cash Flow
of Neurobo Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neurobo Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neurobo Pharmaceuticals Inc

Current Assets 28.5m
Cash & Short-Term Investments 27.9m
Other Current Assets 583k
Non-Current Assets 234k
PP&E 213k
Other Non-Current Assets 21k
Current Liabilities 9.7m
Accounts Payable 2.6m
Accrued Liabilities 2.6m
Other Current Liabilities 4.5m
Non-Current Liabilities 98k
Other Non-Current Liabilities 98k
Efficiency

Earnings Waterfall
Neurobo Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-26.5m USD
Operating Income
-26.5m USD
Other Expenses
621k USD
Net Income
-25.9m USD

Free Cash Flow Analysis
Neurobo Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NRBO Profitability Score
Profitability Due Diligence

Neurobo Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

33/100
Profitability
Score

Neurobo Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

NRBO Solvency Score
Solvency Due Diligence

Neurobo Pharmaceuticals Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Neurobo Pharmaceuticals Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NRBO Price Targets Summary
Neurobo Pharmaceuticals Inc

There are no price targets for NRBO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NRBO?

Click here to dive deeper.

Dividends

Neurobo Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NRBO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NRBO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Neurobo Pharmaceuticals Inc Logo
Neurobo Pharmaceuticals Inc

Country

United States of America

Industry

Biotechnology

Market Cap

21.8m USD

Dividend Yield

0%

Description

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. The company is headquartered in Boston, Massachusetts and currently employs 5 full-time employees. The company went IPO on 2016-08-05. The firm is engaged in the development and commercialization of therapeutics. The company is focused on four therapeutics programs designed to impact a range of indications in viral, neurodegenerative and cardiometabolic disease. The Company’s therapeutics programs include ANA001, NB-01, NB-02 and Gemcabene. Its ANA001, is an oral niclosamide formulation and was developed as a treatment for patients with moderate coronavirus disease (COVID-19). NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy and treat a range of neuropathic conditions. Its NB-02, which treats the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid beta plaque deposition. The Company’s Gemcabene, which is being assessed as an acute indication for COVID-19 treatments.

Contact

MASSACHUSETTS
Boston
200 Berkeley St., Fl 19
+18577029600.0
www.neurobopharma.com

IPO

2016-08-05

Employees

5

Officers

See Also

Discover More
What is the Intrinsic Value of one NRBO stock?

The intrinsic value of one NRBO stock under the Base Case scenario is 3.4 USD.

Is NRBO stock undervalued or overvalued?

Compared to the current market price of 2.65 USD, Neurobo Pharmaceuticals Inc is Undervalued by 22%.

Back to Top